Novel pathogenic variants in GBE1 causing fetal akinesia deformation sequence and severe neuromuscular form of glycogen storage disease type IV

Clin Dysmorphol. 2019 Jan;28(1):17-21. doi: 10.1097/MCD.0000000000000248.

Abstract

Glycogen storage disease IV (GSD IV), caused by a defect in GBE1, is a clinically heterogeneous disorder. A classical hepatic form and a neuromuscular form have been described. The severe neuromuscular form presents as a fetal akinesia deformation sequence or a congenital subtype. We ascertained three unrelated families with fetuses/neonates who presented with fetal akinesia deformation sequence to our clinic for genetic counseling. We performed a detailed clinical evaluation, exome sequencing, and histopathology examination of two fetuses and two neonates from three unrelated families presenting with these perinatally lethal neuromuscular forms of GSD IV. Exome sequencing in the affected fetuses/neonates identified four novel pathogenic variants (c.1459G>T, c.144-1G>A, c.1680C>G, and c.1843G>C) in GBE1 (NM_000158). Histopathology examination of tissues from the affected fetuses/neonate was consistent with the diagnosis. Here, we add three more families with the severe perinatally lethal neuromuscular forms of GSD IV to the GBE1 mutation spectrum.

Publication types

  • Case Reports

MeSH terms

  • Arthrogryposis / enzymology*
  • Arthrogryposis / genetics*
  • Arthrogryposis / pathology
  • Base Sequence
  • Female
  • Fetus / pathology
  • Glycogen Debranching Enzyme System / genetics*
  • Glycogen Storage Disease Type IV / enzymology*
  • Glycogen Storage Disease Type IV / genetics*
  • Glycogen Storage Disease Type IV / pathology
  • Humans
  • Infant, Newborn
  • Male
  • Mutation / genetics*
  • Neuromuscular Diseases / enzymology*
  • Neuromuscular Diseases / genetics*
  • Neuromuscular Diseases / pathology
  • Pedigree

Substances

  • Glycogen Debranching Enzyme System
  • GBE1 protein, human

Supplementary concepts

  • Pena Shokeir syndrome, type 1